Paradigm Health

paradigm.inc

-16%

est. 2Y upside i

HealthcareSeries B

Paradigm Health is rebuilding the clinical research ecosystem by creating a platform that enables equitable access to trials for all patients, while enhancing trial efficiency and reducing the barriers to participation for healthcare providers.

Rank

#2666

Sector

Healthcare Technology

Est. Liquidity

~5Y

Data Quality

Data: Low

The equity upside is highly uncertain due to complete lack of financial data.

Last updated: July 21, 2026

Bull (20%)+100%

Assuming strong adoption and FDA collaboration leading to high growth; equity value doubles to $1.5B despite 20% dilution.

Base (55%)0%

Valuation stagnant at $750M; no material exit progress within 2 years; dilution reduces effective upside to near zero.

Bear (25%)-100%

Failure to achieve commercial traction or regulatory setbacks; preference stack ($281M) wipes out common equity, resulting in total loss.

Est. time to liquidity~5.0 years

Preference Stack Risk

severe

Funding Intensity

3750%

Total preferred stock ($281M) equals 37% of assumed entry valuation ($750M), severely diluting common equity in downside scenarios.

Dilution Risk

high

With $281M raised and no path to breakeven disclosed, additional funding rounds are likely within 2 years, further diluting common holders by an estimated 20%.

Secondary Liquidity

none

No secondary market activity reported; liquidity expected only upon exit (IPO or acquisition), likely 4-5 years away.

Questions to Ask at the Interview

Strategic questions based on Paradigm Health's data — designed to show you've done your homework.

  • 1

    What is your current annual recurring revenue and growth rate?

  • 2

    How do you plan to achieve profitability and reduce reliance on venture funding?

  • 3

    What are the typical equity grant sizes and liquidity opportunities for employees?

Community

Valuation Sentiment

Our model estimates -16% upside. What do you think?

Anonymous. Do not share material non-public information.


Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.